Competition is brewing for Novo Nordisk and Eli Lilly, two of the world’s leading pharmaceutical weight loss companies, according to analysts.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
16 new weight loss drugs to enter market by 2029, economists say
